Bill Sponsor
House Bill 5775
115th Congress(2017-2018)
PROPER Act of 2018
Active
Active
Passed House on Jun 19, 2018
Overview
Text
Introduced
May 11, 2018
Latest Action
Jun 20, 2018
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
5775
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Republican
Minnesota
Republican
Pennsylvania
Democrat
Pennsylvania
Democrat
Wisconsin
House Votes (1)
Senate Votes (0)
checkPassed on June 19, 2018
Status
Passed
Type
Voice Vote
Voice Vote
A vote in which the presiding officer states the question, then asks those in favor and against to say "Yea" or "Nay," respectively, and announces the result according to his or her judgment. The names or numbers of senators voting on each side are not recorded.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5256-5257)
Summary

Providing Reliable Options for Patients and Educational Resources Act of 2018 or the PROPER Act of 2018

This bill requires Medicare and Medicare Advantage (MA) prescription drug plan (PDP) sponsors to annually disclose information to enrollees about: (1) the risks of prolonged opioid use; and (2) the plan's coverage of nonpharmacological therapies, devices, and non-opioid medications. PDP sponsors may limit disclosure to a subset of enrollees (such as those who were prescribed an opioid in the previous two-year period).

The bill also requires Medicare medication therapy management programs and MA in-home health risk assessments to include information about the safe disposal of prescription drugs.

The bill prohibits inclusion of pain management questions in certain health care system surveys, unless the questions address the risks of opioid use and the availability of non-opioid alternatives.

Text (4)
June 20, 2018
June 19, 2018
June 19, 2018
Actions (15)
06/20/2018
Received in the Senate and Read twice and referred to the Committee on Finance.
06/19/2018
Motion to reconsider laid on the table Agreed to without objection.
06/19/2018
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5256-5257)
06/19/2018
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5256-5257)
06/19/2018
DEBATE - The House proceeded with forty minutes of debate on H.R. 5775.
06/19/2018
Considered under suspension of the rules. (consideration: CR H5256-5258)
06/19/2018
Mr. Curbelo (FL) moved to suspend the rules and pass the bill, as amended.
06/19/2018
Placed on the Union Calendar, Calendar No. 594.
06/19/2018
Committee on Energy and Commerce discharged.
06/19/2018
Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-763, Part I.
06/04/2018
Referred to the Subcommittee on Health.
05/16/2018
Ordered to be Reported (Amended) by Voice Vote.
05/16/2018
Committee Consideration and Mark-up Session Held.
05/11/2018
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
05/11/2018
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:39:32 PM